Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid
Cognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions Cognoa, a pediatric…
